Technology | January 19, 2010

New Suite of Tools Aids Cardiovascular Research

January 19, 2010 – A family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro was launched today by iWorks. The systems, software and components are used for a number of research applications, including measuring and analyzing blood pressure, electrocardiograms, blood flow and cardiac output, pressure-volume, sonomicrometry dimension and volume, isolated Langendorff and working heart models and isolated tissue studies.

iWorx LabScribe2 recording and analysis software provides a comprehensive set of preconfigured routines to simplify data interpretation and analysis. Specific software modules for cardiovascular research are available to analyze pressure signals, blood flow data, ECG recordings, ventricular pressure-volume loops and sonomicrometry dimension data. The software can display up to 128 channels of data simultaneously at sampling rates as high as 100,000 samples/second.

iWorx cardiovascular research solutions include complete tissue baths systems, blood flow systems, and myograph systems. A wide range of transducers, amplifiers, signal conditioners, multi-channel data recorders and accessories can be used for in situ experiments, isolated heart preparations and isolated tissue protocols.

For more information: www.iworx.com.


Related Content

News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
News | Cardiovascular Clinical Studies

Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...

Home January 14, 2025
Home
News | Cardiovascular Clinical Studies

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
Subscribe Now